NEK8 Antikörper (AA 101-200) (AbBy Fluor® 555)
Kurzübersicht für NEK8 Antikörper (AA 101-200) (AbBy Fluor® 555) (ABIN907981)
Target
Alle NEK8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 101-200
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Dog,Cow,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human NEK8
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- NEK8 (NIMA-Related Kinase 8 (NEK8))
-
Andere Bezeichnung
- NEK8
-
Hintergrund
-
Synonyms: JCK, NEK 8, NEK12A, NEK8, NEK8_HUMAN, Never in mitosis A-related kinase 8, NIMA-family kinase NEK8, NIMA-related kinase 12a, Nima-related protein kinase 12a, NimA-related protein kinase 8, Serine/threonine-protein kinase Nek8.
Background: Required for renal tubular integrity.Tissue specificity: Highest expression in thyroid, adrenal gland and skin. Low levels in spleen, colon and uterus. Overexpressed in breast tumors, with highest expression in infiltrating ductal carcinomas and moderate levels in mucinous adenocarcinoma.
-
Gen-ID
- 284086
Target
-